A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease

Timothy G. Lesnick1, Spiridon Papapetropoulos2, Deborah C. Mash2, Jarlath Ffrench-Mullen3, Lina Shehadeh4, Mariza de Andrade1, John R. Henley5, Walter A. Rocca6,7, J. Eric Ahlskog7, Demetrius M. Maraganore7* 1 Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America, 2 Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida, United States of America, 3 Gene Logic, Gaithersburg, Maryland, United States of America, 4 Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, Florida, United States of America, 5 Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America, 6 Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America, 7 Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America